DnB Asset Management AS
- SEC CIK
- 0001456670
- Latest filing
- Aug 11, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −9,585−100.0% | Sold out | Holders |
| Q2 2025 | 9,585 | $452.4K | <0.1% | −726−7.0% | Reduced | Holders |
| Q1 2025 | 10,311 | $402.9K | <0.1% | +1,955+23.4% | Added | Holders |
| Q4 2024 | 8,356 | $452.5K | <0.1% | +847+11.3% | Added | Holders |
| Q3 2024 | 7,509 | $378.6K | <0.1% | +137+1.9% | Added | Holders |
| Q2 2024 | 7,372 | $324.1K | <0.1% | +1,694+29.8% | Added | Holders |
| Q1 2024 | 5,678 | $285.2K | <0.1% | +5,678 | New | Holders |